Experimental tablet for moderate to severe Ulcerative Colitis
Part of Digestive system, Immune system & allergy clinical trials.
This trial tests an experimental tablet, HRS-7085, for people with moderate to severe Ulcerative Colitis who haven't gotten enough help from standard treatments. The goal is to see if the drug can reduce inflammation and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have active Ulcerative Colitis that has been diagnosed for at least 3 months.
- Your Ulcerative Colitis is moderate to severe (with symptoms like frequent diarrhea and visible blood in stool).
- You have tried at least one standard treatment (like mesalamine, steroids, or biologic drugs) and it didn't work well enough, stopped working, or caused side effects.
- You do not have Crohn's disease, or other conditions like severe colitis or a history of bowel cancer.
- You are willing to use effective birth control if you or your partner could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing an investigational medication for moderate to severe ulcerative colitis (UC) that has not responded well to other treatments. The goal is to see if the drug can help reduce inflammation and improve symptoms.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.
This trial tests a new medicine to see if it's safe for people with moderate to severe ulcerative colitis. It also tests the medicine in healthy volunteers to check for side effects. If you have ulcerative colitis, this might offer a new treatment option.
This trial tests an experimental drug (ISM5411) for people with active ulcerative colitis. The goal is to see if the drug can reduce inflammation and improve symptoms.
This trial tests a new treatment for people with ulcerative colitis (UC) whose disease is active despite taking only mesalamine or sulfasalazine. It aims to find a therapy that can reduce inflammation and improve symptoms.
Hear when a new Adult Patients With Moderately to Severely Active Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.